Literature DB >> 15074760

Human reproductive cloning, embryo stem cells and germline gene intervention: an Israeli perspective.

Michel Revel1.   

Abstract

The perspectives of applying the cloning technology to human reproduction have generated much controversy. Israel was one of the first countries to adopt (in 1998) a Law that prohibits reproductive cloning. This is a moratorium for 5 years during which neither cloning of an entire human being nor genetic changes affecting human reproductive cells will be allowed. An aim of the Law is to allow the examination of the moral, legal, and social aspects of these technologies and their implications for human dignity. With the intention of not being an obstacle to the advancement of medical genetics, the Law provides for a yearly report to the Israel Health Minister on the state of scientific knowledge in these technologies. This article reflects the 2002-3 report, relating to scientific issues and bioethical opinions in Israel and in the world on human reproductive cloning, embryonic stem cell research and germline gene manipulation. In the Jewish tradition, the primary importance of saving lives and helping suffering patients can take precedence over the fears generated by modern genetic and reproductive research. Provided that new technologies are applied for medical indications and respecting human rights and human dignity, it is legitimate to explore their beneficial potential.

Entities:  

Keywords:  Biomedical and Behavioral Research; Genetics and Reproduction; Legal Approach

Mesh:

Year:  2003        PMID: 15074760

Source DB:  PubMed          Journal:  Med Law        ISSN: 0723-1393


  3 in total

Review 1.  Stem-cell research: the state of the art. Future regulations of embryonic-stem-cell research will be influenced more by economic interests and cultural history than by ethical concerns.

Authors:  Sven Pompe; Michael Bader; Christof Tannert
Journal:  EMBO Rep       Date:  2005-04       Impact factor: 8.807

2.  Derivation of xeno-free and GMP-grade human embryonic stem cells--platforms for future clinical applications.

Authors:  Shelly E Tannenbaum; Tikva Tako Turetsky; Orna Singer; Einat Aizenman; Sophie Kirshberg; Nili Ilouz; Yaniv Gil; Yael Berman-Zaken; Temima Schnitzer Perlman; Nitshia Geva; Ora Levy; Daniel Arbell; Alex Simon; Assaf Ben-Meir; Yoel Shufaro; Neri Laufer; Benjamin E Reubinoff
Journal:  PLoS One       Date:  2012-06-20       Impact factor: 3.240

3.  Systematic scoping review of the concept of 'genetic identity' and its relevance for germline modification.

Authors:  Floor M Goekoop; Carla G van El; Guy A M Widdershoven; Nadza Dzinalija; Martina C Cornel; Natalie Evans
Journal:  PLoS One       Date:  2020-01-24       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.